StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 12/02/2013 -- StockRunway.com issues special report on –Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Sigma Labs Inc (OTCMKTS:SGLB), Ariad Pharmaceuticals, Inc (NASDAQ:ARIA), DryShips Inc (NASDAQ:DRYS)
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) opened the session at $70.04 and closed at $70.05. The stock showed a positive performance of 0.46% in the last trading session. The stock traded on a volume of 290,688.00 shares and the average volume of the stock remained 366,831.00 shares. Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions:
Will RHHBY Continue To Move Higher? Find Out Her
Sigma Labs Inc (OTCMKTS:SGLB) traded 7.24 million shares in the last business day while the average volume of the stock remained 6.88 million shares. The stock showed a positive movement of 0.39% to end at $0.258. Sigma Labs, Inc. has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies, as well as Reasearch and Development solutions for first-tier integrators and other commercial firms worldwide. Sumner Associates provide consultants to Federal government and commercial clients seeking productive solutions for development technologies. As of December 31, 2012,
For How Long SGLB will fight for Profitability? Read This Trend Analysis report
Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) the stock escalated 6.61% and finished the day at $4.84. The beta of the stock is recorded at 4.44. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
Why Should Investors Buy ARIA After The Recent Gain? Just Go Here and Find Out
DryShips Inc (NASDAQ:DRYS) the stock advanced 4.56% and finished the session at $3.44. Traded with volume of 14.38 million shares in the prior session and the average volume of the stock remained 12.01 million shares. DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units. As of December 31, 2011, it owned and operated two fifth generation ultra-deepwater, semi-submersible offshore drilling rigs,
Will DRYS Continue To Move Higher? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)